Press releaseGlobe Newswire
Absci
ABSI · NASDAQ
$9.07+$0.53 (+6.21%)TodayMarket closed ·
Prev close $8.54
Latest news
- News
10 Health Care Stocks With Whale Alerts In Today’s Session
- NewsAvi Kapoor
Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
- Press releaseGlobe Newswire
Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
- NewsVandana Singh
Eli Lilly Utilizes Weight-Loss Drug Profits To Fund Women's Health Initiatives: Report
- Press releasePRNewswire
AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030
- Press releaseGlobe Newswire
Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does.
- NewsAvi Kapoor
National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releaseGlobe Newswire
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
- Press releasePRNewswire
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
- Press releasePRNewswire
As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22
- Press releasePRNewswire
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
- Press releasePRNewswire
The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel
- NewsSurbhi Jain
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsVandana Singh
Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- Press releaseGlobe Newswire
Absci Announces Pricing of $100 Million Underwritten Offering with Leading Strategic and Financial Investors
- Press releaseGlobe Newswire
Absci Announces Positive Interim Phase 1 Data from the HEADLINE™ Trial of ABS-201, a Novel Antibody Targeting the Prolactin Receptor (PRLR)
- Press releasePRNewswire
The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It
- Press releaseBusiness Wire
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- NewsAvi Kapoor
Absci, DigitalOcean And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Why Blaize Holdings Shares Are Trading Higher By Around 41%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releasePRNewswire
AI Creation Engines Transform Biotech as Wellness Tech Captures Growth Wave
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
- News
Absci's Earnings: A Preview
- NewsRounak Jain
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics
- NewsAvi Kapoor
Gold Falls Over 1%; Phillips 66 Posts Upbeat Earnings
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
Assessing Absci: Insights From 6 Financial Analysts
- NewsVishaal Sanjay
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
- NewsAvi Kapoor
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday
- News
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
- News
A Glimpse Into The Expert Outlook On Absci Through 7 Analysts
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- Press releasePRNewswire
FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.